Back
Spyre Therapeutics Quote, Financials, Valuation and Earnings
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
44
SYRE
Spyre Therapeutics
Last Price:
32.98
Seasonality Move:
2.92%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.Spyre Therapeutics Price Quote
$32.98
-1.27 (-3.71%)
(Updated: May 8, 2024 at 6:55 PM ET)
Spyre Therapeutics Key Stats
Sell
44
Spyre Therapeutics (SYRE)
is a Sell
Day range:
$33.40 - $35.91
52-week range:
$2.66 - $47.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
334.30
P/B ratio:
0%
Volume:
175.6K
Avg. volume:
353.9K
1-year change:
756.25%
Market cap:
$1.2B
Revenue:
$886K
EPS:
$-72.84
How Much Does Spyre Therapeutics Make?
Data Unavailable
Is Spyre Therapeutics Growing As A Company?
Data Unavailable
Spyre Therapeutics Stock Price Performance
-
Did Spyre Therapeutics Stock Go Up Last Month?
Spyre Therapeutics share price went down by -5.33% last month -
Did SYRE's Share Price Rise Over The Last Year?
SYRE share price rose by 756.25% over the past 1 year
What Is Spyre Therapeutics 52-Week High & Low?
-
What Is Spyre Therapeutics’s 52-Week High Share Price?
Spyre Therapeutics has traded as high as $47.97 over the past 52 weeks -
What Is Spyre Therapeutics’s 52-Week Low Share Price?
Spyre Therapeutics has traded as low as $2.66 over the past 52 weeks
Spyre Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Spyre Therapeutics?
-
How Much Debt Does Spyre Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Spyre Therapeutics Have?
Cash and short term investments quarterly total is $339.3M -
What Is Spyre Therapeutics’s Book Value Per Share?
Book value per share is -0.03
Is Spyre Therapeutics Cash Flow Positive?
-
What Is SYRE Cash Flow From Operations?
Cash flow from operations (TTM) is -$99.9M -
What Is Spyre Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $361.1M -
What Is Spyre Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$108.4M
Spyre Therapeutics Return On Invested Capital
Data Unavailable
Spyre Therapeutics Earnings Date & Stock Price
-
What Is Spyre Therapeutics's Stock Price Today?
A single share of SYRE can be purchased today for 34.25 -
What Is Spyre Therapeutics’s Stock Symbol?
Spyre Therapeutics trades on the nasdaq under the ticker symbol: SYRE -
When Is Spyre Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Spyre Therapeutics is scheduled on May 10, 2024 -
When Is SYRE's next ex-dividend date?
Spyre Therapeutics's next ex-dividend date is May 9, 2024 -
How To Buy Spyre Therapeutics Stock?
You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Spyre Therapeutics Competitors
-
Who Are Spyre Therapeutics's Competitors?
Below is a list of companies who compete with Spyre Therapeutics or are related in some way:
Spyre Therapeutics Dividend Yield
Data Unavailable
Spyre Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -389.13% |
| Revenue: | 0% | -100% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 43.14 |
| Upside from Last Price: | 25.96% |